A cereblon (CRBN) molecular glue degrader of NIMA-related kinase 7 (NEK7) reveals a context-dependent role in NLRP3 inflammasome activation
Authors: Sylvain Aude , Stoehr Natacha , Ma Fupeng , Cernijenko Artiom , Schröder Martin , Khoshouei Maryam , Vogelsanger Melanie , Schoenboerner Michel , Burke Ashley , Pasupuleti Rao , Solomon Jonathan , Paulk Joshiawa , Xu Lei , Dawson Janet , Begue Damien , Lefeuvre Peggy , Ahrne Erik , Hofmann Andreas , Dickson Callum J. , Arabin Philip , Zimmerlin Alfred , Kiffe Michael , Froehlicher Mirjam , Boersig Theresa , Elhajouji Azeddine , Brichet Murielle , Menon Sue , Liu Shanming , Mueller Matthias , Wartchow Charles , Lin James , Cardona Gloria Yamel , Dickhöfer Sabine , Weber Alexander N. R. , Welzel Tatjana , Kuemmerle-Deschner Jasmin , Farady Christopher J. , Pulz Robert , Bornancin Frederic , Buckley Dennis L. , Bassi Zuni I. 
Published: November 2024

SummaryThe NLRP3 (NACHT-, leucine-rich repeat [LRR]- and pyrin domain [PYD]- containing protein 3) inflammasome is a cytoplasmic signaling complex that promotes inflammation in response to signals from infection and cellular damage. Increased activation of the NLRP3 inflammasome is linked to numerous diseases including gout, osteoarthritis, cardiovascular disease, neuroinflammatory diseases and cancer, which has prompted the search for therapeutics that can inhibit the NLRP3 pathway.Recent work suggested that NIMA-related kinase 7 (NEK7) may be required for proper assembly and activation of the NLRP3 inflammasome independent of its kinase activity, and that hence reduction of NEK7 protein levels may block NLRP3 activation. Since NEK7 contains a glycine beta hairpin loop structural degron found in many targets of cereblon (CRBN) molecular glue degraders, we used this strategy to degrade NEK7 and inhibit the NLRP3 inflammasome. We identified NK7-902, a CRBN glue degrader of NEK7. NK7-902 potently and selectively degraded NEK7 in human primary monocytes, peripheral blood mononuclear cells (PBMCs) and whole blood. Unexpectedly, full NEK7 degradation led to only partial blockade of NLRP3-dependent interleukin-1β (IL-1β) release in these cells under different stimulation conditions, with the extent of IL-1β inhibition varying greatly across donors.Unlike most CRBN glue degraders, NK7-902 degraded NEK7 in mouse cells and efficiently inhibited NLRP3-dependent IL-1β release in a mouse cryopyrin-associated syndrome (CAPS) model. By contrast, oral administration of NK7-902 in non-human primates led to profound and long lasting NEK7 degradation but only transiently blocked IL-1β production in blood.Collectively, our data suggest that NEK7 is involved but may not be strictly required for NLRP3 activation in primates and humans.HighlightsIdentification of NK7-902, a CRBN molecular glue degrader of NEK7NK7-902 fully degrades NEK7 in human primary monocytes and whole blood but only partially inhibits NLRP3-dependent IL-1β productionUnlike most CRBN glue degraders, NK7-902 shows activity in murine systemsIn vivo oral administration of NK7-902 in non-human primates leads to profound and long-lasting NEK7 degradation but only transiently blocks NLRP3 inflammasome activation